Search

everythinglearnresearchcommunity

for

Search:↓

The treatment increased hair growth and thickness in patients with hair loss.

Canakinumab's effect on COVID-19 outcomes is unclear.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Keratinocytes can reduce the survival of certain melanoma cells, suggesting new therapy paths.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Dermoscopy helped diagnose a rare skin disease which slightly improved with treatment.

Ocrelizumab helped control lupus in a pregnant patient, leading to the birth of a healthy baby.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Cosmerna ARI effectively reduces hair loss and increases hair density in Europeans with androgenetic alopecia.

Recombinant Human Annexin A5 may help treat localized scleroderma by reducing skin thickening and inflammation.

Alitretinoin helped clear up a skin condition called generalized granuloma annulare in an elderly man.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

Gluconolactone products can significantly reduce skin scaling in golden retrievers with ARCI.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

The combination therapy may be more effective for mild alopecia areata, especially in patients with allergies.

The research found that a protein called caveolin-1 is reduced in psoriasis, but reintroducing it can help alleviate some psoriasis symptoms.

Granzyme B is important in autoimmune skin diseases and could be a new treatment target.

Goserelin injections can effectively manage hyperandrogenism symptoms in postmenopausal women who can't have surgery.

Compound glycyrrhizin combined with conventional treatments effectively and safely promotes hair regrowth in alopecia areata patients.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

GLP-1 receptor agonists can cause skin and hair issues due to rapid weight loss, but these can be managed with proper care and treatments.

Higher Galectin-3 levels are linked to insulin resistance and may predict androgenetic alopecia severity.